APP and Alzheimer disease: We present multiple lines of evidence from neuronal APP models and DS patient fibroblasts and additional support from analyses of Alzheimer brains, indicating that APPL1 is the mediator of βCTF-induced rab5 activation, which underlies the very early-appearing endocytic dysfunction in AD.